APGE (Apogee Therapeutics, Inc.) Stock Market Reviews

crown

search

Read and share opinions on APGE (Apogee Therapeutics, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock marke

APGE

Apogee Therapeutics, Inc.

clarify Biotechnology

bookmark Healthcare

public United States

Sell Neutral Buy

Latest News

Is Apogee Therapeutics Inc. (APGE) Outperforming Other Medical Stocks This Year?
Nov 11, 2025
Apogee Therapeutics to Participate in Upcoming Conferences
Nov 3, 2025
Wall Street Analysts Believe Apogee Therapeutics Inc. (APGE) Could Rally 69.3%: Here's is How to Trade
Oct 30, 2025
BTIG Maintains a Buy on Apogee Therapeutics (APGE)
Oct 18, 2025
Does Apogee Therapeutics Inc. (APGE) Have the Potential to Rally 72.52% as Wall Street Analysts Expect?
Oct 14, 2025
Apogee Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $345 Million
Oct 10, 2025
Apogee Therapeutics (APGE): Assessing Valuation Following $300 Million Equity Raise
Oct 10, 2025
Apogee Therapeutics, Inc. Announces Pricing of $300 Million Underwritten Public Offering
Oct 9, 2025
Apogee Therapeutics, Inc. Announces Proposed Underwritten Public Offering
Oct 8, 2025
RBC Capital Initiates Coverage of Apogee Therapeutics (APGE) With an Outperform Rating
Sep 30, 2025
Apogee Therapeutics Shares Poised for Upside as Pipeline Targets Multiple Immunology Indications, RBC Says
Sep 25, 2025
BofA Raises Apogee Therapeutics (APGE) PT to $87 Following Positive Phase 2 APEX Trial Results for Atopic Dermatitis
Sep 15, 2025
Apogee Therapeutics (APGE) To Showcase APG777 At EADV Congress 2025
Sep 12, 2025

Reviews